Regulatory Updates
🇺🇸 FDA Page 28FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 325–336 of 373 articles
Novel Drug Approvals for 2026: Insights from the FDA
DIA 2024: What to Expect at This Year's Event
Novo Nordisk Reports Record Q1 Revenue Driven by Wegovy and Ozempic Demand
FDA Approves Eli Lilly's Zepbound for Obstructive Sleep Apnea
BIO 2026 Preview: Companies to Watch and Key Catalysts
Inflation Reduction Act Pharmaceutical Impact: What You Need to Know
ANVISA Regulatory Changes: Impact on Fast-Track Approvals for Oncology Drugs
FDA Accelerated Approvals Oncology: 2026 Policy Review & Zongertinib Case
FDA Accelerated Approval Oncology: 2026 Review of Evolving Pathways
Pharma Compliance Congress 2026 Opens: Key Regulatory Themes
FDA Labeling Changes for Oral Semaglutide: Cardiovascular Risk Insights
African Medicines Agency impact: What You Need to Know